北京万东医疗科技股份有限公司 2025年股票期权激励计划预留授予 激励对象名单（预留授予日） 2025 年 8 月 22 日 注：上表中部分合计数与各明细数相加之和在尾数上如有差异，系百分比结果四舍五入所致。 二、核心骨干人员、董事会认为需要激励的其他人员名单（以下排名不分先后） | 序号 | 姓名 | 激励对象类别 | | --- | --- | --- | | 1 | 李莹 | 核心管理人员、核心技术/业务人员 | | 2 | 庞国粱 | 核心管理人员、核心技术/业务人员 | | 3 | 赵吉君 | 核心管理人员、核心技术/业务人员 | | 4 | 李震 | 核心管理人员、核心技术/业务人员 | | 5 | 冒坚 | 核心管理人员、核心技术/业务人员 | | 6 | 曹冬阁 | 核心管理人员、核心技术/业务人员 | | 7 | 李锴 | 核心管理人员、核心技术/业务人员 | | 8 | 陈守水 | 核心管理人员、核心技术/业务人员 | | 9 | 周铭捷 | 核心管理人员、核心技术/业务人员 | | 10 | 张静 | 核心管理人员、核心技术/业务人员 | | 11 | 耿浩 | 核心管理人员、核心技术/ ...

一、本次激励计划预留授予的内容与公司2024年年度股东大会审议 通过的内容一致。 北京万东医疗科技股份有限公司 董事会薪酬与考核委员会 关于公司2025年股票期权激励计划 预留授予激励对象名单（授予日）的核查意见 北京万东医疗科技股份有限公司（以下简称"公司"）董事会薪酬 与考核委员会依据《中华人民共和国公司法》《中华人民共和国证券法》 《上市公司股权激励管理办法》（以下简称"《管理办法》"）等有关法 律、法规及规范性文件和《北京万东医疗科技股份有限公司章程》（以 下简称"《公司章程》"）的有关规定，对公司2025年股票期权激励计 划（以下简称"本次激励计划"）预留授予激励对象名单（授予日）进 行审核，发表核查意见如下： （5）法律法规规定不得参与上市公司股权激励的； （6）中国证监会认定的其他情形； （7）公司董事会认定其他严重违反公司有关规定的。 四、公司和本次激励计划预留授予激励对象均未出现《管理办法》 及本次激励计划规定的不能授予或不得成为激励对象的情形，本次激励 计划的预留授予条件已经成就。 五、董事会确定的本次激励计划的预留授予日符合《管理办法》和 本次激励计划关于授予日的规定。 二、本次激励计划 ...

股票简称：万东医疗 证券代码：600055 独立财务顾问报告 二零二五年八月 | 4 | | --- | | | 华泰联合证券有限责任公司 关于 北京万东医疗科技股份有限公司 向2025年股票期权激励计划 激励对象授予预留股票期权 之 | 目录 2 | | --- | | 一、释义 3 | | 二、声明 4 | | 三、基本假设 5 | | 四、本次激励计划已履行的审批程序和信息披露情况 6 | | 五、独立财务顾问意见 8 | | 六、备查文件及咨询方式 11 | | （二）咨询方式 11 | 一、释义 本报告中，除非文义载明，下列简称具有如下含义： | 万东医疗、公司 | 指 | 北京万东医疗科技股份有限公司 | | --- | --- | --- | | 本激励计划、本计划 | 指 | 北京万东医疗科技股份有限公司 2025 年股票期权激励计划（草 | | | | 案） | | 股票期权、期权 | 指 | 公司授予激励对象在未来一定期限内以预先确定的价格和条件购 | | | | 买公司一定数量股票的权利 | | 激励对象 | 指 | 按照本激励计划规定，获得股票期权的公司（含子公司）董事、 | | | ...

北京市嘉源律师事务所 关于北京万东医疗科技股份有限公司 2025 年股票期权激励计划 预留授予事项的法律意见书 西城区复兴门内大街 158 号远洋大厦 4 楼 中国 · 北京 律师事务所 A YUAN LAW OFFICES 致:北京万东医疗科技股份有限公司 北京市嘉源律师事务所 关于北京万东医疗科技股份有限公司 2025 年股票期权激励计划预留授予事项的法律意见书 嘉源(2025)-05-294 敬启者: 根据《中华人民共和国公司法》(以下简称"《公司法》")、《中华人民共和 国证券法》(以下简称"《证券法》")、中国证券监督管理委员会(以下简称"中 国证监会")《上市公司股权激励管理办法》(以下简称"《管理办法》")和《北 京万东医疗科技股份有限公司章程》(以下简称"《公司章程》")等有关规定, 北京市嘉源律师事务所(以下简称"本所")接受北京万东医疗科技股份有限公司 (以下简称"万东医疗"或"公司")的委托,就万东医疗 2025年股票期权激励 计划(以下简称"本次激励计划")向激励对象授予预留股票期权(以下简称"本 次授予")相关事项出具本法律意见书。 本所依据本法律意见书出具目以前已经发生或存在的事实 ...

格隆汇8月22日｜万东医疗公告，2025年上半年营业收入8.43亿元，同比增长20.46%。净利润5129.86万 元，同比下降39.46%。公司2025年中期不进行利润分配或资本公积转增股本。 ...

万东医疗公告，2025年上半年营业收入8.43亿元，同比增长20.46%。净利润5129.86万元，同比下降 39.46%。公司2025年中期不进行利润分配或资本公积转增股本。 ...

Core Insights - The Chinese AI + medical imaging industry is rapidly developing, with a market size projected to reach 7.6 billion yuan in 2024, representing a year-on-year growth of 109.94% [1][11] - AI technology is capable of quickly identifying small lesions from vast amounts of imaging data, facilitating precise early screening for various diseases and providing significant diagnostic support for doctors [1][11] - The product types in AI medical imaging are diversifying, with a trend towards integrated hardware and software solutions becoming the preferred choice for medical institutions [1][11] Industry Overview - AI + medical imaging refers to the use of AI technologies, such as deep learning and computer vision, to analyze and process medical images (e.g., X-rays, CT scans, MRIs, ultrasounds) to assist doctors in disease diagnosis, treatment planning, and prognosis evaluation [1][4] - The core function includes auxiliary diagnosis, treatment planning, prognosis assessment, and early detection screening [1][4] Industry Value Chain - The upstream of the AI + medical imaging industry includes medical imaging equipment, chips, servers, storage devices, imaging acquisition and processing software, cloud services, network operation platforms, and algorithm and data platforms [4] - The midstream involves the development and manufacturing of AI + medical imaging technologies, while the downstream primarily serves medical institutions, health check centers, and research and educational institutions [4] Market Size - The market size of the Chinese medical imaging equipment industry is expected to reach 69.3 billion yuan in 2024, with a year-on-year growth of 9.83% [6] Relevant Policies - The Chinese government has issued several policy documents to support and regulate the development of the AI + medical imaging industry, emphasizing the optimization of medical device standards and the establishment of standardization organizations for AI and medical robotics [8][10] - The policies aim to accelerate approval processes, enhance innovation ecosystems, and improve international competitiveness [8][10] Key Companies and Performance - Major companies in the AI + medical imaging sector include United Imaging Healthcare, Wandong Medical, Mindray, and Shukun Technology, each leveraging unique strengths in hardware and AI software integration [13][15] - United Imaging Healthcare reported a revenue of 10.3 billion yuan in 2024, a decrease of 9.73% year-on-year, while its R&D investment increased by 17.84% to 2.261 billion yuan [15] - Shukun Technology focuses on providing comprehensive AI solutions for medical institutions, achieving significant market penetration with its innovative products [17] Industry Development Trends 1. The industry is expected to advance towards multi-modal data integration and deep learning, enhancing diagnostic accuracy and personalized treatment [20] 2. Applications of AI in medical imaging will expand from auxiliary diagnosis to full-process management, improving service efficiency and quality [21] 3. Regulatory frameworks will evolve to include data privacy protections and accountability mechanisms for AI-generated content [22]

通过天眼查大数据分析，北京万东医疗科技股份有限公司共对外投资了17家企业，参与招投标项目2533 次，知识产权方面有商标信息244条，专利信息260条，此外企业还拥有行政许可84个。 来源：金融界 万东医疗最新一期业绩显示，截至2025一季报，公司营业总收入3.73亿元、同比增长21.00%，归属净利 润3505.22万元，同比增长5.40%，扣非净利润2326.89万元，同比减少25.77%，流动比率9.955、速动比 率9.505、资产负债率8.98%。 天眼查商业履历信息显示，北京万东医疗科技股份有限公司，成立于1997年，位于北京市，是一家以从 事医药制造业为主的企业。企业注册资本70306.1058万人民币，实缴资本70306.1058万人民币。公司法 定代表人为宋金松。 金融界消息 截至2025年8月15日收盘，万东医疗（600055）报收于17.58元，上涨0.29%，换手率 1.01%，成交量7.08万手，成交金额1.24亿元。 资金流向方面，今日主力资金净流出1107.67万元，占比成交额8.92%。其中，超大单净流出1353.89万 元、占成交额10.9%，大单净流入246.22万元、占成 ...

Group 1 - Midea has integrated the cleaning-related business from the microwave and cleaning division into the washing machine division to enhance industry focus and synergy [1] - The restructuring decision was approved by the group and aims to complete the transfer of budgets, assets, personnel, and inventory by August 21 [1] - The microwave and cleaning division has been renamed to the microwave and oven division following this adjustment [1] Group 2 - The previous president of the microwave and cleaning division, Ma Chibing, has transitioned to lead Midea's medical business and is no longer in charge of the division [2] - Midea's subsidiary, Wandong Medical, reported a revenue of 1.524 billion yuan for 2024, reflecting a year-on-year growth of 23.26%, while net profit decreased by 16.54% [2] Group 3 - Midea's microwave and cleaning division has over 13,000 employees and an annual sales scale exceeding 19 billion yuan, with a presence in multiple countries [3] - The division's products are exported to over 180 countries, serving more than 100 million domestic users [3] - Currently, there are 251 job openings in the division across various roles and locations [3] Group 4 - The washing machine division is currently led by President Xiao Yi, who has established a social media presence [4] - The previous president of the washing machine division, Zhao Lei, has been reassigned to the home air conditioning division [4] Group 5 - Midea has undergone significant organizational changes since 2025, including the integration of refrigerator, washing machine, and kitchen appliance divisions [5] - Reports indicate that Midea may lay off approximately 30,000 employees in 2025, following the consolidation of sales operations [5] - The company has streamlined its regional operations from 35 to 29 provincial sales companies, resulting in an estimated reduction of 900 employees [5]

Investment Rating - The industry investment rating is maintained at "Outperform the Market" [4] Core Viewpoints - The total bid amount for medical devices in July 2025 reached 12.643 billion yuan, representing a year-on-year increase of 20% and a cumulative total of 96.785 billion yuan from January to July, with an overall year-on-year growth of 57% [5][11] - Domestic device bidding amounts are recovering, with categories like endoscopes showing high year-on-year growth rates [6] - Imported brands experienced a slight decline in bidding amounts, but categories such as CT and DSA showed significant year-on-year growth [7] Summary by Sections Medical Device Bidding Overview - The total bidding amount for medical devices in July 2025 was 12.643 billion yuan, a 20% increase year-on-year, but a 6% decrease month-on-month [11] - From January to July 2025, the total bidding amount was 96.785 billion yuan, reflecting a 57% year-on-year increase [11] Domestic Brands - Mindray Medical's total bidding amount in July was 1.017 billion yuan, up 84% year-on-year, with a cumulative total of 5.854 billion yuan from January to July, also up 57% [15] - Aohua Endoscopy's total bidding amount in July was 68.22 million yuan, a 23% increase year-on-year, with a cumulative total of 303.27 million yuan from January to July, reflecting a 48% increase [21] - Kailing Medical's total bidding amount in July was 101 million yuan, a 67% increase year-on-year, with a cumulative total of 740 million yuan from January to July, showing a 106% increase [24] - Shanfeng's total bidding amount in July was 49 million yuan, a staggering 392% increase year-on-year, with a cumulative total of 236 million yuan from January to July, reflecting a 239% increase [27] - Wandong Medical's total bidding amount in July was 66.17 million yuan, a 19% increase year-on-year, with a cumulative total of 794.41 million yuan from January to July, showing a 95% increase [30] Imported Brands - Philips' total bidding amount in July was 467.37 million yuan, a 41% decrease year-on-year, with a cumulative total of 5.045 billion yuan from January to July, reflecting a 39% increase [33] - Siemens' total bidding amount in July was 554 million yuan, an 11% decrease year-on-year, with a cumulative total of 6.620 billion yuan from January to July, showing a 49% increase [36] - GE's total bidding amount in July was 701.17 million yuan, a 17% decrease year-on-year, with a cumulative total of 7.414 billion yuan from January to July, reflecting a 44% increase [39]